182 related articles for article (PubMed ID: 19729974)
1. Imatinib in gastrointestinal stromal tumor: does treatment duration matter?
Adenis A; Penel N; Blay JY
Oncology; 2009; 77(3-4):157-61. PubMed ID: 19729974
[TBL] [Abstract][Full Text] [Related]
2. Clinical outcome in gastrointestinal stromal tumor patients who interrupted imatinib after achieving stable disease or better response.
Lee JL; Ryu MH; Chang HM; Kim TW; Kang HJ; Sohn HJ; Lee JS; Kang YK
Jpn J Clin Oncol; 2006 Nov; 36(11):704-11. PubMed ID: 17068083
[TBL] [Abstract][Full Text] [Related]
3. Metastatic gastrointestinal stromal tumors in the era of imatinib: improved survival and elimination of socioeconomic survival disparities.
Artinyan A; Kim J; Soriano P; Chow W; Bhatia S; Ellenhorn JD
Cancer Epidemiol Biomarkers Prev; 2008 Aug; 17(8):2194-201. PubMed ID: 18708414
[TBL] [Abstract][Full Text] [Related]
4. The challenge of opportunities: how far can and should we go with targeted treatments and modern diagnostics in gastrointestinal stromal tumors?
Bauer S; Lang H
Eur J Gastroenterol Hepatol; 2007 Aug; 19(8):619-22. PubMed ID: 17625429
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of metastatic gastrointestinal stromal tumors with Imatinib: report of four cases].
Garrido S M; Moneada M M; Tapia N G; Méndez O G; Galindo A H; Huete G A; Ibáñez A L; González S; Alvarez Z M
Rev Med Chil; 2007 Oct; 135(10):1327-32. PubMed ID: 18180842
[TBL] [Abstract][Full Text] [Related]
6. Approval summary: imatinib mesylate in the treatment of metastatic and/or unresectable malignant gastrointestinal stromal tumors.
Cohen MH; Farrell A; Justice R; Pazdur R
Oncologist; 2009 Feb; 14(2):174-80. PubMed ID: 19193781
[TBL] [Abstract][Full Text] [Related]
7. Should surgical resection be combined with imatinib therapy for locally advanced or metastatic gastrointestinal stromal tumors?
Yoon SS; Tanabe KK
Ann Surg Oncol; 2007 Jun; 14(6):1784-6. PubMed ID: 17356951
[No Abstract] [Full Text] [Related]
8. Current incidence and outcomes of gastrointestinal mesenchymal tumors including gastrointestinal stromal tumors.
Perez EA; Livingstone AS; Franceschi D; Rocha-Lima C; Lee DJ; Hodgson N; Jorda M; Koniaris LG
J Am Coll Surg; 2006 Apr; 202(4):623-9. PubMed ID: 16571433
[TBL] [Abstract][Full Text] [Related]
9. Hepatic arterial embolization and chemoembolization for imatinib-resistant gastrointestinal stromal tumors.
Kobayashi K; Szklaruk J; Trent JC; Ensor J; Ahrar K; Wallace MJ; Madoff DC; Murthy R; Hicks ME; Gupta S
Am J Clin Oncol; 2009 Dec; 32(6):574-81. PubMed ID: 19636238
[TBL] [Abstract][Full Text] [Related]
10. Imatinib mesilate for the treatment of gastrointestinal stromal tumour.
Cassier PA; Dufresne A; Arifi S; El Sayadi H; Labidi I; Ray-Coquard I; Tabone S; Méeus P; Ranchère D; Sunyach MP; Decouvelaere AV; Alberti L; Blay JY
Expert Opin Pharmacother; 2008 May; 9(7):1211-22. PubMed ID: 18422477
[TBL] [Abstract][Full Text] [Related]
11. [An update of the surgical indications for gastrointestinal stromal tumors].
Bonvalot S
J Chir (Paris); 2008; 145 Suppl 3():6S8-11. PubMed ID: 19060842
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant imatinib treatment improves recurrence-free survival in patients with high-risk gastrointestinal stromal tumours (GIST).
Nilsson B; Sjölund K; Kindblom LG; Meis-Kindblom JM; Bümming P; Nilsson O; Andersson J; Ahlman H
Br J Cancer; 2007 Jun; 96(11):1656-8. PubMed ID: 17533389
[TBL] [Abstract][Full Text] [Related]
13. Development of hypogammaglobulinemia in patients treated with imatinib for chronic myeloid leukemia or gastrointestinal stromal tumor.
Santachiara R; Maffei R; Martinelli S; Arcari A; Piacentini F; Trabacchi E; Alfieri P; Ferrari A; Leonardi G; Luppi G; Longo G; Vallisa D; Marasca R; Torelli G
Haematologica; 2008 Aug; 93(8):1252-5. PubMed ID: 18519520
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant imatinib for gastrointestinal stromal tumors: the current situation and problems.
Zhong JH; Ma L; Li LQ; Ru HM; Zhao YN
Scand J Gastroenterol; 2011 Jun; 46(6):645-51. PubMed ID: 21271901
[TBL] [Abstract][Full Text] [Related]
15. Should adjuvant imatinib be used as primary treatment for gastrointestinal stromal tumors?
Hohenberger P
Nat Clin Pract Oncol; 2008 May; 5(5):240-1. PubMed ID: 18349856
[No Abstract] [Full Text] [Related]
16. Metastatic gastrointestinal stromal tumor with long-term response after treatment with concomitant radiotherapy and imatinib mesylate.
Boruban C; Sencan O; Akmansu M; Atik ET; Ozbek S
Anticancer Drugs; 2007 Sep; 18(8):969-72. PubMed ID: 17667604
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant and down-staging treatment with imatinib in gastrointestinal stromal tumors.
Nilsson B; Andersson A; Ahlman H
J Surg Oncol; 2008 Sep; 98(3):145-6. PubMed ID: 18452216
[No Abstract] [Full Text] [Related]
18. [Surgical treatment of an advanced GIST the age of imatinib].
Fernández JA; Parrilla P
Cir Esp; 2009 Jul; 86(1):3-12. PubMed ID: 19539273
[TBL] [Abstract][Full Text] [Related]
19. CASE 3. Pathologic complete remission of metastatic gastrointestinal stromal tumor after imatinib mesylate.
Chacón M; Roca E; Huertas E; Loria FS; Domenechini E
J Clin Oncol; 2005 Mar; 23(7):1580-2. PubMed ID: 15735135
[No Abstract] [Full Text] [Related]
20. Giant gastrointestinal stromal tumor with remarkable preoperative response to imatinib mesylate.
Stokes A; Herndon MD; Conforti AM
Am Surg; 2010 Aug; 76(8):903-4. PubMed ID: 20726426
[No Abstract] [Full Text] [Related]
[Next] [New Search]
